2,6-Diaminopurine

2,6-Diaminopurine

SCHEMBL29143272

CC.Nc1nc(N)c2[nH]cnc2n1

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.92
GDA Q9Y2T3 1/20 0.92
CDK2 P24941 11/20 0.61
DPP4 P27487 1/20 0.61
MAP3K5 Q99683 1/20 0.61
CDK1 P06493 11/20 0.56
CCNB1 P14635 11/20 0.56
CCNA2 P20248 10/20 0.56
CCNA1 P78396 10/20 0.56
PIN1 Q13526 1/20 0.53
PI4KA P42356 2/20 0.52
PI4K2B Q8TCG2 2/20 0.52
PI4K2A Q9BTU6 2/20 0.52
PI4KB Q9UBF8 2/20 0.52
LMNA P02545 1/20 0.52
DRD3 P35462 1/20 0.52
XDH P47989 1/20 0.52
LRRK2 Q5S007 1/20 0.52
HRH4 Q9H3N8 1/20 0.51
MGMT P16455 3/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2,6-Diaminopurine SCHEMBL24053 0.96 PDPK1 (1.00) PDPK1GDACDK2DPP4MAP3K5
2,6-Diaminopurine SCHEMBL28206545 0.94 PDPK1 (0.96) PDPK1GDACDK2DPP4MAP3K5
2,6-Diaminopurine SCHEMBL8757979 0.94 PDPK1 (0.96) PDPK1GDACDK2DPP4MAP3K5
2,6-Diaminopurine SCHEMBL27891733 0.94 PDPK1 (0.96) PDPK1GDACDK2DPP4MAP3K5
2,6-Diaminopurine SCHEMBL28083713 0.89 PDPK1 (0.79) PDPK1GDACDK2DPP4MAP3K5
2,6-Diaminopurine SCHEMBL1033682 0.87 PDPK1 (0.82) PDPK1GDACDK2DPP4MAP3K5
2,6-Diaminopurine SCHEMBL30680639 0.85 PDPK1 (0.79) PDPK1GDACDK2DPP4MAP3K5
2,6-Diaminopurine SCHEMBL4535059 0.85 PDPK1 (0.79) PDPK1GDACDK2DPP4MAP3K5
2,6-Diaminopurine SCHEMBL13857840 0.85 PDPK1 (0.79) PDPK1GDACDK2DPP4MAP3K5
2,6-Diaminopurine SCHEMBL3238169 0.85 PDPK1 (0.79) PDPK1GDACDK2DPP4MAP3K5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110114464-B Methods of treating cancer by targeting antisense oligonucleotides to PRDM15 新加坡科技研究局 2023-12-26 CN disclosed